Skip to main content
OpenTrials

Clinical trial condition

Lobular Breast Carcinoma

Explore clinical trials studying Lobular Breast Carcinoma. Study availability and eligibility vary by location and protocol.

14 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Lobular Breast Carcinoma trial results

Recruiting

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

NCT05964504

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Abramson Cancer Center Philadelphia, Pennsylvania, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

NCT07483307

Conditions
Adenocarcinoma, Breast Cancer, Breast Diseases, +14 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

NCT05837767

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +65 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Completed

Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours

NCT03620643

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • Royal Marsden NHS Foundation Trust London, United Kingdom
  • Guys and St Thomas NHS Foundation Trust London, United Kingdom
  • University College London Hospital London, United Kingdom
View Trial Details

Related conditions